<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01302717</url>
  </required_header>
  <id_info>
    <org_study_id>LVPACE</org_study_id>
    <nct_id>NCT01302717</nct_id>
  </id_info>
  <brief_title>Left Ventricular Pacing to Avoid Cardiac Enlargement Study</brief_title>
  <acronym>LVPACE</acronym>
  <official_title>Impact of Left Ventricular Pacing on Left Ventricular Systolic Function in High-risk Bradycardia Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the investigators will examine whether left ventricular pacing is superior to
      right ventricular apical pacing in preventing deterioration of left ventricular systolic
      function and cardiac remodeling in patients with bradycardia with high risk for development
      of pacing-induced heart failure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this prospective, we will randomly assign 98 patients who need permanent pacemaker due to
      complete atrioventricular block or sick sinus syndrome to receive left ventricular pacing (49
      patients) or right ventricular apical pacing (49 patients). Patients will be paced with
      temporary pacemaker lead, and only those with paced QRS duration ≥185 ms will be enrolled.

      The primary endpoint is left ventricular ejection fraction measured by modified Simpson
      method at 12 months. The secondary end points include left ventricular systolic end-systolic
      and diastolic volume, LV strain, NYHA functional class, exercise performance (using treadmill
      test), quality of life (using SF-36v2), NT-proBNP at 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Left ventricular ejection fraction (%) at 12 months</measure>
    <time_frame>12 months</time_frame>
    <description>Measured by modified Simpson's method</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Left ventricular end-systolic volume (ml) at 12 months</measure>
    <time_frame>12 months</time_frame>
    <description>Measured by modified Simpson method</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left ventricular end-diastolic volume (ml) at 12 months</measure>
    <time_frame>12 months</time_frame>
    <description>Measured by modified Simpson method</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NYHA functional class</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional capacity</measure>
    <time_frame>12 months</time_frame>
    <description>measured by treadmill test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>12 months</time_frame>
    <description>measured by SF-36v2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NT-proBNP</measure>
    <time_frame>12 months</time_frame>
    <description>plasma level</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">98</enrollment>
  <condition>Complete AV Block</condition>
  <condition>Sick Sinus Syndrome</condition>
  <arm_group>
    <arm_group_label>Right ventricular pacing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Left ventricular pacing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LV pacing</intervention_name>
    <description>The left ventricular lead are positioned preferentially at the posterolateral or lateral venous branches of the coronary sinus.</description>
    <arm_group_label>Left ventricular pacing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RV pacing</intervention_name>
    <description>The right ventricular lead are positioned at the right ventricular apex.</description>
    <arm_group_label>Right ventricular pacing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sinus-node dysfunction or bradycardia due to advanced atrioventricular block

          -  Paced QRS duration ≥185 ms

        Exclusion Criteria:

          -  Left ventricular ejection fraction &lt; 50 %

          -  Acute coronary syndrome

          -  If they had undergone percutaneous coronary intervention or coronary-artery bypass
             surgery within the previous 3 months

          -  if they had a life expectancy of less than 1 year

          -  if they had received a heart transplant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seil Oh, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Seil Oh, MD, PhD</last_name>
    <phone>82-2-2072-2088</phone>
    <email>seil@snu.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Si-Hyuck Kang, MD</last_name>
    <phone>82-2-2072-3757</phone>
    <email>eandp303@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <zip>464-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Il-Young Oh, MD</last_name>
      <phone>82-31-787-7056</phone>
      <email>spy510@snu.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Il-Young Oh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seil Oh, MD, PhD</last_name>
      <phone>82-2-2072-2088</phone>
      <email>seil@snu.ac.kr</email>
    </contact>
    <contact_backup>
      <last_name>Eue-Keun Choi, MD, PhD</last_name>
      <phone>82-2-2072-0688</phone>
      <email>choiek417@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Seil Oh, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2011</study_first_submitted>
  <study_first_submitted_qc>February 23, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 24, 2011</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Seil Oh</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Left ventricular pacing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sick Sinus Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

